Abstract
Abstract
The effects of specific human platelet-secreted proteins on prostacyclin (PGI2) production by primary cultures of bovine aortic endothelial cells have been studied. Cells were incubated with various concentrations of highly purified preparations of platelet factor 4(PF4), low-affinity platelet factor 4 (LA-PF4), β-thromboglobulin (βTG), platelet basic protein (PBP), and partially purified plateletderived growth factor (PDGF) in the presence or absence of arachidonic acid (AA). The amount of 6-Keto-PGF1α, the stable degradation product of PGI2, was determined in the cell incubation medium by means of a specific radioimmunoassay. Short-term (15 min) incubation of cell monolayers with either LA-PF4 or βTG slightly reduced 6-keto-PGF1α production. The effect was not dose-related and could not be observed after prolonged (24 hr) incubation of the cells with the same proteins. It was not seen in the cell suspensions. Moreover, 6-keto-PGF1α production stimulated by AA was not affected by incubation with either of the proteins. PF4 and PBP had no significant effect on 6-keto-PGF1α production by endothelial cells. Human PDGF showed a slight tendency to stimulate 6-keto-PGF1α release when cells were incubated for 24 hr with the protein; however, PDGF did not potentiate the stimulatory effect of AA on 6-keto-PGF1α release by the cells. We suggest that plateletderived proteins exert only a moderate and possibly nonspecific effect on PGI2 production by endothelial cells.
Get full access to this article
View all access options for this article.
